抗血小板的
Antiplatelet therapy is recommended for symptomatic patients. 推荐抗血小板治疗症状性患者。
Conclusion: The antiplatelet drugs utilization needs further standardization. 结论：临床需进一步规范使用抗血小板药物。
Evidence based case report Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy? 原发性脑出血患者是否应该进行抗血小板或抗凝治疗?
Antiplatelet Therapy for Secondary Prevention of Cardiovascular Events: More "Advanced" Drug, More Perfect? 心血管事件的二级预防:抗血小板治疗药物越“先进”越完美吗?
Title:Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 抗血小板预防可否减少肝移植术后肝动脉栓塞的发生率?
